Lupin Strikes Deal In Suit Over Generic Lunesta

Law360, New York (January 3, 2011, 4:11 PM EST) -- Lupin Ltd. on Monday announced that it had reached a settlement with Sunovion Pharmaceuticals Inc. in a lawsuit over a generic version of the sleep aid Lunesta.

Under the settlement, Lupin and its subsidiary, Lupin Pharmaceuticals Inc., would be able to sell a generic version of Lunesta by the end of November 2013, approximately two months before the expiration of one of the patents-in-suit, 6,444,673.

If Sunovion receives six months of additional pediatric exclusivity for Lunesta, the licensing agreement would go into effect at the end...
To view the full article, register now.